Skip to main content

Lonza in two expansion deals

Lonza its to expand its two-year collaboration with Moderna to manufacture the drug substance for Moderna’ COVID-19 vaccine. This will lead to further expansion at its main site in Visp, Switzerland, as will another small molecule complex, which includes a dedicated line for antibody-drug conjugates (ADCs) for an unnamed customer.

Solvay, Ashland complete buys

Two recent acquisitions that are both largely focused in the personal care arena were both completed almost simultaneously. Solvay completed the sale of its amphoteric surfactant business to OpenGate Capital, while Ashland finalised that of the personal care business of Schülke & Mayr from investment firm EQT.

AMRI targets rare diseases

Pharmaceutical CDMO AMRI has invested both in terms of scale and compound handling capabilities and new expert personnel to address orphan and rare disease products. No figure has been disclosed of the sum involved.

At its headquarters site in Albany, New York, AMRI has added additional suites for 10-15 kg batch sizes. At Grafton, Wisconsin, it has expanded its hydrogenation, filtering and drying and analytical capabilities, the latter including LC-MS and GC-MS instruments, as well as new experts. The company has also expanded at Glasgow, UK.

Novozymes trials probiotic cleaner

Industrial enzymes giant Novozymes, several cleaning companies, start-up firm Aks2tal and the Danish municipality of Gladsaxe have formed a local partnership to test the former’s probiotic cleaning product, Microvia Pro. This is taking place in office and canteen areas at multiple locations in Gladsaxe over six weeks from 3 May onwards.

Standard Industries to acquire Grace

A five-month battle over the ownership of W. R. Grace & Co. came to an end on 26 April, when the company entered into a definitive agreement with Standard Industries Holdings will acquire it in an all-cash transaction valued at approximately $7.0 billion. This includes Grace’s pending acquisition of Albemarle Fine Chemistry Services (FCS).

Climate recommendations from ACC

The American Chemistry Council (ACC) has issued a set of policy recommendations, which, it says could “enable dramatic reductions in greenhouse gas emissions” and help the administration to achieve its climate goals. Specifically, it called on Congress to enact legislation to

1. Increase government investment and scientific resources to develop and deploy low emission technologies in the manufacturing sector

2. Adopt transparent, predictable, technology- and revenue-neutral, market-based, economy-wide carbon price signals; and

Subscribe to Current issue